4//SEC Filing
Grant Richard N. Jr. 4
Accession 0001062993-24-008309
CIK 0001036262other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 5:34 PM ET
Size
14.4 KB
Accession
0001062993-24-008309
Insider Transaction Report
Form 4
INTEST CORPINTT
Grant Richard N. Jr.
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-04-09$12.80/sh−20,000$256,000→ 215,217 total - Sale
Common Stock
2024-04-10$12.03/sh−22,000$264,660→ 193,217 total - Sale
Common Stock
2024-04-11$12.03/sh−21,500$258,645→ 171,717 total
Holdings
- 16,988
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (16,988 underlying) - 25,692
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (25,692 underlying) - 30,536
Employee Stock Option (right to buy)
Exercise: $11.33Exp: 2034-03-05→ Common Stock (30,536 underlying) - 112,000
Employee Stock Option (right to buy)
Exercise: $10.62Exp: 2031-03-09→ Common Stock (112,000 underlying)
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $13.23, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.83 to $12.56, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.91 to $12.20, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]This option vests in four equal annual installments commencing on March 6, 2025.
- [F6]This option vests in four equal annual installments commencing on March 8, 2024.
- [F7]This option vests in four equal annual installments commencing on March 9, 2023.
- [F8]This option vests in four equal annual installments commencing on March 10, 2022.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001821315
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 5:34 PM ET
- Size
- 14.4 KB